Karen L. Mossman focuses on Virology, Virus, Interferon, Immunology and Immune system. Her study in Herpes simplex virus, Viral replication and Viral transformation is done as part of Virology. Her Herpes simplex virus research includes themes of Vero cell, Immediate early protein and Herpes simplex virus protein vmw65.
Her biological study spans a wide range of topics, including IRF7, IRF3 and Interferon regulatory factors. Karen L. Mossman focuses mostly in the field of Immunology, narrowing it down to matters related to Cancer cell and, in some cases, Acquired immune system and Antigen presentation. The Immune system study which covers Gene product that intersects with Transactivation, Mutant, Virulence and Open reading frame.
Karen L. Mossman spends much of her time researching Virology, Virus, Interferon, Immunology and Immune system. Virology and MDA5 are commonly linked in her work. Her research integrates issues of Molecular biology, Gene product and Gene in her study of Virus.
Her Interferon study combines topics in areas such as Innate immune system, IRF3, Interferon regulatory factors and Cell biology. Her work on Immunotherapy as part of general Immune system study is frequently connected to Context, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her Herpes simplex virus research is multidisciplinary, incorporating elements of Immediate early protein and Herpes simplex virus protein vmw65.
Her scientific interests lie mostly in Virology, Virus, Cancer research, Immune system and Oncolytic virus. The various areas that Karen L. Mossman examines in her Virology study include Gene, MHC class II and IRF3. Her work deals with themes such as Interferon and In vitro, which intersect with Virus.
Karen L. Mossman has included themes like Cancer, Immunotherapy, Hepatitis C, Transfection and Cytotoxic T cell in her Cancer research study. Her studies in Immune system integrate themes in fields like Infectivity, Peripheral blood mononuclear cell, Permissive and Vaccination. Her Oncolytic virus research includes elements of Cancer cell, Viral replication, Breast cancer and Herpes simplex virus.
Karen L. Mossman mainly investigates Immune system, Cancer research, Oncolytic virus, Cancer cell and Immunogenic cell death. Her Immune system research is multidisciplinary, incorporating perspectives in 2019-20 coronavirus outbreak, Viral replication and Virology. Her work on Virus and Infectivity as part of general Virology research is frequently linked to Betacoronavirus, thereby connecting diverse disciplines of science.
Her studies deal with areas such as Phenotype, Interferon and Permissive as well as Virus. In Oncolytic virus, Karen L. Mossman works on issues like Herpes simplex virus, which are connected to Vesicular stomatitis virus. Her Cancer cell research incorporates themes from Advanced melanoma, Neuroscience and Antigen presentation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
Bats and Coronaviruses.
Arinjay Banerjee;Kirsten Kulcsar;Vikram Misra;Matthew Frieman.
Encoding of a homolog of the IFN-gamma receptor by myxoma virus.
Chris Upton;Karen Mossman;Grant McFadden.
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian.
Journal for ImmunoTherapy of Cancer (2020)
The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes
Rongtuan Lin;Ryan S. Noyce;Susan E. Collins;Roger D. Everett.
Journal of Virology (2004)
Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response
Karen L. Mossman;Pascale F. Macgregor;Jacob J. Rozmus;Andrew B. Goryachev.
Journal of Virology (2001)
Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells
Claudia U Duerr;Connor D A McCarthy;Barbara C Mindt;Manuel Rubio.
Nature Immunology (2016)
Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon
Karen L. Mossman;Holly A. Saffran;James R. Smiley.
Journal of Virology (2000)
Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication
Susan E. Collins;Ryan S. Noyce;Karen L. Mossman.
Journal of Virology (2004)
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines.
Alshad S. Lalani;Kathryn Graham;Karen Mossman;Krishna Rajarathnam.
Journal of Virology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: